Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover the patented aqueous synthesis method for Cilostazol (CN1257902C). Achieve >99% purity with reduced environmental impact and optimized manufacturing costs.
Patent CN117051414A enables metal-free electrochemical synthesis. Delivers high-purity aryl sulfonyl fluoride with substantial cost reduction and supply chain reliability.
Patent CN85101840A details a novel stereoselective route for 16-phenoxy prostaglandin trienoic acid derivatives, offering improved crystallinity and supply chain reliability for pharmaceutical manufacturers.
Patent CN117343004A reveals mild catalyst-free route reducing cost and improving supply chain reliability for high-purity pharmaceutical intermediates globally.
Patent CN114277006B reveals a novel ADH for synthesizing chiral heterocyclic alcohols without organic solvents, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN114057790B reveals high all-trans vitamin A phosphine salt synthesis. Enables cost reduction in vitamin manufacturing and reliable supply chain stability.
Patent CN102757356B details a cost-effective splitting process for D-HPG. Enhances supply chain reliability and reduces waste in API intermediate manufacturing significantly.
Novel S173Q/Q360Y mutant enzyme boosts D-alanine yield by 20% and stability 3-fold, offering cost-effective pharma intermediate solutions.
Novel patent CN117964457A enables high-purity octafluoronaphthalene production with simplified purification and scalable routes for display materials.
Patent CN112409115B discloses a novel aryl silane route for trifluoromethylthio compounds, offering high selectivity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN116730813A reveals a safer Grignard route for 4,4'-Difluorobenzophenone. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing.
Advanced refining process for Cefotiam hexetil hydrochloride using cost-effective bromo-esterification. High purity, scalable manufacturing for global pharmaceutical supply chains.
Patent CN107266283B introduces a novel diacyl peroxide method for Heck reactions. Achieve high-purity pharmaceutical intermediates with reduced costs and scalable supply chains.
Novel synthesis route for insulin resistance intermediates. Cost-effective scale-up and high purity for diabetes drug manufacturing.
Patent CN1902166A reveals a novel route for Tamsulosin HCl using excess achiral reagent and thermal crystallization, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN117003647A details a Ru-Co alloy catalyst for low-temperature reductive amination, offering high yield and cost efficiency for pharmaceutical intermediate manufacturing.
Patent CN101830959B reveals a novel drospirenone synthesis route using halogenated imides, offering high purity, reduced solvent use, and scalable manufacturing for global supply chains.
Patent CN87105804A details a novel route for L-carnitine intermediates, offering cost reduction in pharma manufacturing and reliable supply chain solutions.
Patent CN106699507B details water-based hydrogenation for high-purity alpha-phenylethanol. This green process ensures supply chain reliability and significant cost reduction.
Patent CN101747352B reveals a novel crystallization method for biapenem intermediates using lower alcohols to enhance purity and filtration efficiency for industrial scale-up.